Kathryn M Anastos

Summary

Country: USA

Publications

  1. ncbi The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy
    Kathryn Anastos
    Montefiore Medical Center, Bronx, New York, USA
    Ann Intern Med 140:256-64. 2004
  2. ncbi The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women
    Kathryn Anastos
    Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 39:537-44. 2005
  3. ncbi The association of bone mineral density with HIV infection and antiretroviral treatment in women
    Kathryn Anastos
    Montefiore Medical Centre, Bronx, NY, USA
    Antivir Ther 12:1049-58. 2007
  4. ncbi Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women
    Kathryn Anastos
    Montefiore Medical Center, Bronx NY, USA
    AIDS Res Ther 7:34. 2010
  5. ncbi Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women
    Kathryn Anastos
    Departments of Medicine and Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, United States of America
    PLoS ONE 5:e13525. 2010
  6. ncbi Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
    Carlos M Vaamonde
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 22:222-31. 2006
  7. ncbi Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease
    Kathryn Anastos
    Department of Internal Medicine, Montefiore Medical Center and Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA
    Arch Intern Med 162:1973-80. 2002
  8. ncbi Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens
    Kathryn Anastos
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 45:34-42. 2007
  9. ncbi Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
    Robert C Kaplan
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    AIDS 22:1615-24. 2008
  10. ncbi Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Acquir Immune Defic Syndr 37:1604-9. 2004

Research Grants

  1. The Women's Interagency HIV Study (WIHS)
    Kathryn Anastos; Fiscal Year: 2007

Detail Information

Publications48

  1. ncbi The prognostic importance of changes in CD4+ cell count and HIV-1 RNA level in women after initiating highly active antiretroviral therapy
    Kathryn Anastos
    Montefiore Medical Center, Bronx, New York, USA
    Ann Intern Med 140:256-64. 2004
    ..The prognostic value of CD4+ cell counts and HIV-1 RNA levels attained after the initiation of highly active antiretroviral therapy (HAART) compared with before the initiation of HAART has not been well defined...
  2. ncbi The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women
    Kathryn Anastos
    Department of Medicine, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 39:537-44. 2005
    ..To determine the association of race with clinical and laboratory outcomes after initiation of highly active antiretroviral therapy (HAART) in HIV-1-infected women in the United States...
  3. ncbi The association of bone mineral density with HIV infection and antiretroviral treatment in women
    Kathryn Anastos
    Montefiore Medical Centre, Bronx, NY, USA
    Antivir Ther 12:1049-58. 2007
    ..Low bone mineral density (BMD) has been reported in HIV-infected women and men...
  4. ncbi Lipoprotein levels and cardiovascular risk in HIV-infected and uninfected Rwandan women
    Kathryn Anastos
    Montefiore Medical Center, Bronx NY, USA
    AIDS Res Ther 7:34. 2010
    ..Lipoprotein profiles in HIV-infected African women have not been well described. We assessed associations of lipoprotein levels and cardiovascular risk with HIV-infection and CD4 count in Rwandan women...
  5. ncbi Risk factors for cervical precancer and cancer in HIV-infected, HPV-positive Rwandan women
    Kathryn Anastos
    Departments of Medicine and Epidemiology and Population Health, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York, United States of America
    PLoS ONE 5:e13525. 2010
    ..We examined factors associated with cervical intraepithelial neoplasia grade 3 or cancer (CIN3+) in Rwandan women infected with both HIV and HPV (HIV+/HPV+)...
  6. ncbi Factors associated with poor immunologic response to virologic suppression by highly active antiretroviral therapy in HIV-infected women
    Carlos M Vaamonde
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, New York 10021, USA
    AIDS Res Hum Retroviruses 22:222-31. 2006
    ..We conclude that higher baseline CD4 count and lower HIV RNA level were associated with poor immunologic response to HAART in women with virologic suppression for at least 6 months. Persistent low level viremia may also contribute...
  7. ncbi Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease
    Kathryn Anastos
    Department of Internal Medicine, Montefiore Medical Center and Lincoln Medical and Mental Health Center, Bronx, NY 10451, USA
    Arch Intern Med 162:1973-80. 2002
    ..The optimal virologic and immunologic stage at which to initiate antiretroviral therapy in individuals infected with human immunodeficiency virus type 1 (HIV-1) is undefined...
  8. ncbi Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens
    Kathryn Anastos
    Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 45:34-42. 2007
    ..The effects of HIV infection, highly active antiretroviral therapy (HAART), and specific antiretroviral agents on lipoproteins in women are not well described...
  9. ncbi Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men
    Robert C Kaplan
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    AIDS 22:1615-24. 2008
    ..To assess the association of HIV infection, HIV disease parameters (including CD4+ T-cell counts, HIV viral load, and AIDS) and antiretroviral medication use with subclinical carotid artery atherosclerosis...
  10. ncbi Herpes zoster in women with and at risk for HIV: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of International Medicine and Infectious Diseases, Department of Medicine, Weill Medical College of Cornell University, New York, NY 10021, USA
    J Acquir Immune Defic Syndr 37:1604-9. 2004
    ..Herpes zoster occurs at all CD4 cell counts in HIV-infected adults. It was hypothesized that even in the era of highly active antiretroviral therapy (HAART), zoster risk is higher in HIV-infected than uninfected women...
  11. ncbi Biologic markers of ovarian reserve and reproductive aging: application in a cohort study of HIV infection in women
    David B Seifer
    Maimonides Medical Center, Department of Obstetrics and Gynecology, Brooklyn, New York, USA
    Fertil Steril 88:1645-52. 2007
    ..To determine whether HIV infection influences early follicular MIS levels, an early marker of ovarian aging...
  12. ncbi Causes of death among women with human immunodeficiency virus infection in the era of combination antiretroviral therapy
    Mardge H Cohen
    Department of Medicine, Cook County Hospital, Chicago, Illinois, USA
    Am J Med 113:91-8. 2002
    ..Our data suggest that to decrease mortality further among HIV-infected women, attention must be paid to treatable conditions, such as hepatitis C, depression, and drug and tobacco use...
  13. ncbi Glycated haemoglobin in diabetic women with and without HIV infection: data from the Women's Interagency HIV Study
    Marshall J Glesby
    Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Antivir Ther 15:571-7. 2010
    ..Limited data suggest that glycated haemoglobin (haemoglobin A1c; A1C) values might not reflect glycaemic control accurately in HIV-infected individuals with diabetes...
  14. ncbi Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy
    Kathryn Anastos
    Women s Interagency HIV Study, Montefiore Medical Center, Bronx, NY 10467, USA
    J Acquir Immune Defic Syndr 35:383-92. 2004
    ..If delayed-type hypersensitivity (DTH) response predicts clinical response in persons using highly active antiretroviral therapy (HAART), it may also prove useful in resource-poor settings...
  15. ncbi The impact of kidney function at highly active antiretroviral therapy initiation on mortality in HIV-infected women
    Michelle M Estrella
    Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA
    J Acquir Immune Defic Syndr 55:217-20. 2010
    ..We re-examined this association in the later HAART period to determine whether chronic kidney disease remains a predictor of death after HAART initiation...
  16. ncbi Associations of insulin-like growth factor (IGF)-I and IGF-binding protein-3 with HIV disease progression in women
    Howard D Strickler
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    J Infect Dis 197:319-27. 2008
    ....
  17. ncbi Longitudinal anthropometric patterns among HIV-infected and HIV-uninfected women
    Jessica E Justman
    Department of Epidemiology, Columbia University, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 47:312-9. 2008
    ..Previous studies suggest that indicators of central adiposity such as waist-to-hip ratio (WHR) and waist circumference may be altered by HIV infection, antiretroviral treatment, or both...
  18. ncbi Mortality among participants in the Multicenter AIDS Cohort Study and the Women's Interagency HIV Study
    Nancy A Hessol
    Department of Medicine, University of California, San Francisco, CA 94122, USA
    Clin Infect Dis 44:287-94. 2007
    ..We examined temporal trends and risk factors for accident- and injury-related mortality among HIV-infected and -uninfected participants in the Women's Interagency HIV Study (WIHS) and the Multicenter AIDS Cohort Study (MACS)...
  19. ncbi Protease inhibitor levels in hair strongly predict virologic response to treatment
    Monica Gandhi
    Department of Medicine, University of California, San Francisco, San Francisco, California, USA
    AIDS 23:471-8. 2009
    ..The currently available methods to assess ARV exposure are limited. Levels of ARVs in hair reflect plasma concentrations over weeks to months, and may provide a novel method for predicting therapeutic responses...
  20. ncbi Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women
    Monica Gandhi
    Department of Medicine, University of California San Francisco, 405 Irving Street, 2nd Floor, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 50:482-91. 2009
    ....
  21. ncbi CCR2 genotype and disease progression in a treated population of HIV type 1-infected women
    Sean Philpott
    Wadsworth Center, New York State Department of Health, Albany, NY, USA
    Clin Infect Dis 39:861-5. 2004
    ..No association was seen between CCR2 genotype and either disease progression or therapeutic response, suggesting that the benefits of treatment most likely overshadow the salutary effects of the V64I polymorphism...
  22. ncbi Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women
    Howard Minkoff
    Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, New York, USA
    J Infect Dis 189:1821-8. 2004
    ..Among HIV-infected women, smoking is associated with a significantly higher prevalence and incidence of HPV infection. Smoking during HIV infection may alter the natural history of HPV infection and increase the risk of cervical disease...
  23. ncbi Plasma homocysteine is not associated with HIV serostatus or antiretroviral therapy in women
    Farbod Raiszadeh
    Department of Medicine, St Luke s Roosevelt Hospital Center, Columbia University College of Physicians and Surgeons, New York, NY, USA
    J Acquir Immune Defic Syndr 51:175-8. 2009
    ..The effects of HIV serostatus and combination antiretroviral therapy (cART) on plasma homocysteine (HCY) are uncertain...
  24. ncbi Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women
    Ann Danoff
    Harbor Health Care Manhattan, VAH and New York University School of Medicine, New York, NY 10010, USA
    J Acquir Immune Defic Syndr 39:55-62. 2005
    ..To assess the frequency of diabetes, prediabetes, and insulin resistance among a subset of participants in the Women's Interagency HIV Study (WIHS)...
  25. ncbi Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy
    Lynda Anne Szczech
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Clin Infect Dis 39:1199-206. 2004
    ..The associations of proteinuria and an elevated creatinine level with progression to acquired immunodeficiency syndrome (AIDS) and death in the era of highly antiretroviral therapy (HAART) have not been fully described...
  26. ncbi Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
    J Natl Cancer Inst 97:577-86. 2005
    ....
  27. ncbi Insomnia symptoms and HIV infection among participants in the Women's Interagency HIV Study
    Girardin Jean-Louis
    Sleep Disorders Center, Department of Medicine, SUNY Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203 2098, USA
    Sleep 35:131-7. 2012
    ..This study assessed the prevalence of insomnia symptoms among women with and without HIV-infection and examined factors associated with insomnia...
  28. ncbi Association of cutaneous anergy with human papillomavirus and cervical neoplasia in HIV-seropositive and seronegative women
    Tiffany G Harris
    Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 21:1933-41. 2007
    ..This study assessed the relationship of anergy test results with cervical infection by human papillomavirus (HPV) and cervical neoplasia in HIV-seropositive and seronegative women...
  29. ncbi Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    JAMA 293:1471-6. 2005
    ....
  30. ncbi Predictors of proteinuria and renal failure among women with HIV infection
    Lynda Anne Szczech
    Division of Nephrology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA
    Kidney Int 61:195-202. 2002
    ..This study examines the risk factors for proteinuria and renal failure in a large cohort of HIV-infected women not selected for the presence of renal disease...
  31. ncbi Short-term bone loss in HIV-infected premenopausal women
    Michael T Yin
    Department of Medicine, Columbia University Medical Center, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 53:202-8. 2010
    ..Low bone mineral density (BMD) has been reported in HIV+ women, but less is known about the longitudinal evolution of BMD and fracture incidence...
  32. ncbi Oxidant stress in HIV-infected women from the Women's Interagency HIV Study
    Marshall J Glesby
    Division of Infectious Diseases, Department of Medicine, Weill Cornell Medical College, New York, NY, USA
    Antivir Ther 14:763-9. 2009
    ..We hypothesized that oxidant stress is associated with plasma homocysteine concentration and risk factors for atherosclerosis in HIV-infected women...
  33. ncbi Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia
    Mark H Kuniholm
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Hepatology 51:1514-22. 2010
    ..CONCLUSION: HLA genotype influences the host capacity to clear HCV viremia. The specific HLA associations observed in the current study are unlikely to be due to chance because they were a priori hypothesized...
  34. ncbi Eligibility criteria for HIV clinical trials and generalizability of results: the gap between published reports and study protocols
    Monica Gandhi
    Department of Medicine, University of California, San Francisco 94122, USA
    AIDS 19:1885-96. 2005
    ....
  35. ncbi Elevated NT-pro-BNP levels are associated with comorbidities among HIV-infected women
    Ather Mansoor
    Division of Cardiology, Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY 11203, USA
    AIDS Res Hum Retroviruses 25:997-1004. 2009
    ..These findings suggest that natriuretic peptide levels are a global marker of comorbidity in the setting of HIV infection...
  36. ncbi Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women
    Howard D Strickler
    Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    J Natl Cancer Inst 95:1062-71. 2003
    ..To address this issue, we examined HPV test results from repeated study visits in the WIHS and from an independent study, the HIV Epidemiology Research Study (HERS)...
  37. ncbi Does patient-provider racial/ethnic concordance influence ratings of trust in people with HIV infection?
    Nancy Lynn Sohler
    Sophie Davis Medical School, City University of New York, 138th Street and Convent Avenue, City College Campus, New York, NY 10031, USA
    AIDS Behav 11:884-96. 2007
    ....
  38. ncbi The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study
    Andrea A Howard
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 54:152-9. 2010
    ..Opiate use is common in HIV-infected and hepatitis C virus (HCV)-infected individuals, however, its contribution to the risk of diabetes mellitus is not well understood...
  39. ncbi Insulin-like growth factor axis and oncogenic human papillomavirus natural history
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    Cancer Epidemiol Biomarkers Prev 17:245-8. 2008
    ..07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV...
  40. ncbi Microalbuminuria is associated with all-cause and AIDS mortality in women with HIV infection
    Christina M Wyatt
    Department of Medicine, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Acquir Immune Defic Syndr 55:73-7. 2010
    ..We investigated whether microalbuminuria is associated with mortality in HIV-infected women not receiving antiretroviral therapy...
  41. ncbi The insulin-like growth factor axis and risk of liver disease in hepatitis C virus/HIV-co-infected women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York 10461, USA
    AIDS 22:527-31. 2008
    ..To investigate the role of the IGF axis in hepatitis C virus (HCV)-related liver disease among high-risk patients, we prospectively evaluated HCV-viremic/HIV-positive women...
  42. ncbi Prevalence and predictors of metabolic syndrome among HIV-infected and HIV-uninfected women in the Women's Interagency HIV Study
    Magdalena E Sobieszczyk
    Division of Infectious Diseases, Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    J Acquir Immune Defic Syndr 48:272-80. 2008
    ..To assess the prevalence of metabolic syndrome (MetSynd) among participants of the Women's Interagency HIV Study and to describe the association of MetSynd with HIV infection, antiretroviral therapies, and sociodemographic factors...
  43. ncbi Aging and HIV infection
    Rakhi Kohli
    Division of Geographic Medicine and Infectious Disease, Department of Medicine, Tufts New England Medical Center, 750 Washington Street 41, Boston, MA 02111, USA
    J Urban Health 83:31-42. 2006
    ..In this paper, we discuss the health issues confronting HIV-infected older adults and areas for future research...
  44. ncbi Variants of human papillomaviruses 16 and 18 and their natural history in human immunodeficiency virus-positive women
    Nicolas F Schlecht
    Albert Einstein College of Medicine, Department of Epidemiology and Population Health, 1300 Morris Park Avenue, Bronx, NY 10461, USA
    J Gen Virol 86:2709-20. 2005
    ..If non-European variants are more oncogenic, the effect may involve a late stage in cervical tumorigenesis...
  45. ncbi Variations in serum müllerian inhibiting substance between white, black, and Hispanic women
    David B Seifer
    Department of Obstetrics and Gynecology, Brooklyn, and Mount Sinai School of Medicine, Maimonides Medical Center, New York, New York 11228, USA
    Fertil Steril 92:1674-8. 2009
    ..To compare serum müllerian inhibiting substance (MIS) levels between white, black, and Hispanic women to determine whether ovarian aging occurs at a different time course for women of different racial groups...
  46. ncbi Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women
    Raphael P Viscidi
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Infect Dis 187:194-205. 2003
    ..Despite the higher prevalence of HPV infection in this group, most HIV-positive women are able to control HPV-16 replication at the cervix, and reactivation, if it occurs, is not very common...
  47. ncbi Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
    Michael J Silverberg
    Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA
    Clin Vaccine Immunol 13:511-9. 2006
    ..Rises among HIV-positive women may more often result from reactivation of a latent HPV infection in the context of HIV-induced immunosuppression, while rises among HIV-negative women may more often result from reinfection with HPV...
  48. ncbi Serum immunoglobulin A response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
    Raphael P Viscidi
    Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    J Infect Dis 188:1834-44. 2003
    ..9-5.4]), but there was no difference in the risk of incident HPV 16 or HPV 16-related infections. This may be evidence of partial type-specific or clade-specific immunity conferred by seropositivity to HPV 16 capsids...

Research Grants2

  1. The Women's Interagency HIV Study (WIHS)
    Kathryn Anastos; Fiscal Year: 2007
    ..In addition, through a small number of additional specimens, we will investigate the association of women's hormones with HPV. ..